speb/financial-data huggingface dataset:
CNS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 492955000.00
CNS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 4087520.00
CNS income_statement (annual, 2024-12-31) — Tax Provision: 46749000.00
CNS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.24
CNS balance_sheet (annual, 2024-12-31) — Total Assets: 812366000.00
CNS balance_sheet (annual, 2024-12-31) — Total Capitalization: 511711000.00
CNS balance_sheet (annual, 2024-12-31) — Total Debt: 141115000.00
CNS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 574903000.00
CNS income_statement (annual, 2024-12-31) — Total Expenses: 344540000.00
CNS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 237463000.00
CNS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 426576000.00
CNS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 222266000.00
CNS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 172877000.00
CNS balance_sheet (annual, 2024-12-31) — Total Tax Payable: 4601000.00
CNS income_statement (annual, 2024-12-31) — Total Unusual Items: 17320000.00
CNS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 17320000.00
CNS balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 6917926.00
CNS balance_sheet (annual, 2024-12-31) — Treasury Stock: 292781000.00
CNS balance_sheet (annual, 2024-12-31) — Working Capital: 370593000.00
CNS income_statement (quarterly, 2025-03-31) — +Operating Expense: 19526000.00
CNS income_statement (quarterly, 2025-03-31) — +Total Revenue: 139838000.00
CNS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 8194000.00
CNS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 79020000.00
CNS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 955669000.00
CNS cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: 593000.00
CNS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 325861000.00
CNS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 51058000.00
CNS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.78
CNS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 183162000.00
CNS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1075000.00
CNS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 140046000.00
CNS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 582000.00
CNS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 65227000.00
CNS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 212209000.00
CNS cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -31710000.00
CNS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -10543000.00
CNS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 2001000.00
CNS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -108948000.00
CNS cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -51086000.00
CNS cash_flow (quarterly, 2025-03-31) — Change In Dividend Payable: -291000.00
CNS cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 2053000.00
CNS cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -117985000.00
CNS cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 265000.00
CNS cash_flow (quarterly, 2025-03-31) — Change In Payable: 4336000.00
CNS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -46750000.00
CNS cash_flow (quarterly, 2025-03-31) — Change In Receivables: -6853000.00
CNS cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 2053000.00
CNS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -171323000.00
CNS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -3893000.00
CNS cash_flow (quarterly, 2025-03-31) — Changes In Cash: -117490000.00
CNS balance_sheet (quarterly, 2025-03-31) — Common Stock: 582000.00
CNS cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -31710000.00
CNS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 507687000.00
CNS cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -25977000.00
CNS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 69743000.00
CNS balance_sheet (quarterly, 2025-03-31) — Current Assets: 295103000.00
CNS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 19323000.00
CNS cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 5709000.00
CNS cash_flow (quarterly, 2025-03-31) — Deferred Tax: 5709000.00
CNS cash_flow (quarterly, 2025-03-31) — Depreciation: 2831000.00
CNS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2831000.00
CNS income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 2357000.00
CNS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2831000.00
CNS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 2357000.00
CNS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 51418000.00
CNS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.77
CNS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 39778000.00
CNS income_statement (quarterly, 2025-03-31) — EBIT: 50569000.00
CNS income_statement (quarterly, 2025-03-31) — EBITDA: 53400000.00
CNS cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 471000.00
CNS balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 19963000.00
CNS cash_flow (quarterly, 2025-03-31) — End Cash Position: 66143000.00
CNS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -10543000.00
CNS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -110023000.00
CNS cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -3553000.00
CNS income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 2381000.00
CNS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -7923000.00
CNS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 17169000.00
CNS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 19169000.00
CNS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 165897000.00
CNS income_statement (quarterly, 2025-03-31) — Gross Profit: 70095000.00
CNS balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 6897000.00
CNS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 507687000.00
CNS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 2001000.00
CNS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 325861000.00
CNS balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 326401000.00
CNS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 140046000.00
CNS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 140046000.00
CNS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 540000.00
CNS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 133665000.00
CNS income_statement (quarterly, 2025-03-31) — Minority Interests: -3511000.00
CNS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -25977000.00
CNS cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 902000.00
CNS income_statement (quarterly, 2025-03-31) — Net Income: 39778000.00
CNS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 39778000.00
CNS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 43289000.00
CNS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 39778000.00
CNS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 39778000.00
CNS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 43289000.00
CNS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 43289000.00
CNS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 3076000.00
CNS cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 46815000.00
CNS balance_sheet (quarterly, 2025-03-31) — Net PPE: 165897000.00
CNS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1075000.00
CNS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 488518000.00
CNS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 51019000.00
CNS income_statement (quarterly, 2025-03-31) — Normalized Income: 37831425.70
CNS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -108948000.00
CNS cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -2651000.00
CNS income_statement (quarterly, 2025-03-31) — Operating Income: 50569000.00
CNS income_statement (quarterly, 2025-03-31) — Operating Revenue: 139326000.00
CNS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 50976952.00
CNS balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -7923000.00
CNS income_statement (quarterly, 2025-03-31) — Other Gand A: 17169000.00
CNS income_statement (quarterly, 2025-03-31) — Other Income Expense: 2381000.00
CNS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1225000.00
CNS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 28295000.00
CNS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 14181000.00
CNS balance_sheet (quarterly, 2025-03-31) — Other Payable: 4232000.00
CNS balance_sheet (quarterly, 2025-03-31) — Other Properties: 165897000.00
CNS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 3874000.00
CNS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 146982000.00
CNS balance_sheet (quarterly, 2025-03-31) — Payables: 19323000.00
CNS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 19323000.00
CNS income_statement (quarterly, 2025-03-31) — Pretax Income: 52950000.00
CNS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 329000.00
CNS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -76329000.00
CNS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1075000.00
CNS balance_sheet (quarterly, 2025-03-31) — Receivables: 82894000.00
CNS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 69269000.00
CNS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2831000.00
CNS cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -25977000.00
CNS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -121933000.00
CNS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 79405000.00
CNS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 17169000.00
CNS balance_sheet (quarterly, 2025-03-31) — Share Issued: 58186178.00
CNS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 11379000.00
CNS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 507687000.00
CNS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 488518000.00
CNS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 434425.70
CNS income_statement (quarterly, 2025-03-31) — Tax Provision: 9661000.00
CNS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.18
CNS balance_sheet (quarterly, 2025-03-31) — Total Assets: 834865000.00
CNS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 507687000.00
CNS balance_sheet (quarterly, 2025-03-31) — Total Debt: 140046000.00
CNS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 641352000.00
CNS income_statement (quarterly, 2025-03-31) — Total Expenses: 89269000.00
CNS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 193513000.00
CNS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 539762000.00
CNS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 174190000.00
CNS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 45198000.00
CNS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 6897000.00
CNS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 2381000.00
CNS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 2381000.00
CNS balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 7209226.00
CNS balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 318708000.00
CNS balance_sheet (quarterly, 2025-03-31) — Working Capital: 275780000.00
CNS income_statement (quarterly, 2025-06-30) — +Operating Expense: 20453000.00
CNS income_statement (quarterly, 2025-06-30) — +Total Revenue: 142441000.00
CNS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 8337000.00
CNS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 72884000.00
CNS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 968684000.00
CNS cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: 782000.00
CNS balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 222317000.00
CNS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 51165000.00
CNS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.72
CNS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 66143000.00
CNS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2134000.00
CNS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 141563000.00
CNS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 582000.00
CNS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 95372000.00
CNS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 230118000.00
CNS cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -31713000.00
CNS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 93807000.00
CNS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 2531000.00
CNS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -67637000.00
CNS cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 19984000.00
CNS cash_flow (quarterly, 2025-06-30) — Change In Dividend Payable: 143000.00
CNS cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: -11864000.00
CNS cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -126480000.00
CNS cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -132000.00
CNS cash_flow (quarterly, 2025-06-30) — Change In Payable: -7893000.00
CNS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 12091000.00
CNS cash_flow (quarterly, 2025-06-30) — Change In Receivables: -4167000.00
CNS cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: -11864000.00
CNS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -118688000.00
CNS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 5878000.00
CNS cash_flow (quarterly, 2025-06-30) — Changes In Cash: 28701000.00
CNS balance_sheet (quarterly, 2025-06-30) — Common Stock: 582000.00
CNS cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -31713000.00
CNS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 528501000.00
CNS cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -621000.00
CNS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 72346000.00
CNS balance_sheet (quarterly, 2025-06-30) — Current Assets: 307165000.00
CNS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 12625000.00
CNS cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -2231000.00
CNS cash_flow (quarterly, 2025-06-30) — Deferred Tax: -2231000.00
CNS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2828000.00
CNS income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 2375000.00
CNS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2828000.00
CNS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 2375000.00
CNS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 51471000.00
CNS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.72
CNS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 36849000.00
CNS income_statement (quarterly, 2025-06-30) — EBIT: 49642000.00
CNS income_statement (quarterly, 2025-06-30) — EBITDA: 52470000.00
CNS cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 886000.00
CNS balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 39947000.00
CNS cash_flow (quarterly, 2025-06-30) — End Cash Position: 95730000.00
CNS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 93807000.00
CNS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -69771000.00
CNS cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -6715000.00
CNS income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 4192000.00
CNS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -3958000.00
CNS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 18078000.00
CNS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 20034000.00
CNS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 167491000.00
CNS income_statement (quarterly, 2025-06-30) — Gross Profit: 70095000.00
CNS balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 192000.00
CNS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 528501000.00
CNS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 2531000.00
CNS balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 222317000.00
CNS balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 222884000.00
CNS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 141563000.00
CNS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 141563000.00
CNS balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 567000.00
CNS balance_sheet (quarterly, 2025-06-30) — Minority Interest: 13820000.00
CNS income_statement (quarterly, 2025-06-30) — Minority Interests: -4923000.00
CNS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -621000.00
CNS cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 1050000.00
CNS income_statement (quarterly, 2025-06-30) — Net Income: 36849000.00
CNS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 36849000.00
CNS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 41772000.00
CNS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 36849000.00
CNS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 36849000.00
CNS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 41772000.00
CNS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 41772000.00
CNS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 4665000.00
CNS cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 125891000.00
CNS balance_sheet (quarterly, 2025-06-30) — Net PPE: 167491000.00
CNS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2134000.00
CNS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 508467000.00
CNS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 48278000.00
CNS income_statement (quarterly, 2025-06-30) — Normalized Income: 33692424.00
CNS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -67637000.00
CNS cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -5665000.00
CNS income_statement (quarterly, 2025-06-30) — Operating Income: 49642000.00
CNS income_statement (quarterly, 2025-06-30) — Operating Revenue: 142026000.00
CNS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 50993657.00
CNS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -3958000.00
CNS income_statement (quarterly, 2025-06-30) — Other Gand A: 18078000.00
CNS income_statement (quarterly, 2025-06-30) — Other Income Expense: 4192000.00
CNS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1404000.00
CNS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 33449000.00
CNS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 14567000.00
CNS balance_sheet (quarterly, 2025-06-30) — Other Payable: 4096000.00
CNS balance_sheet (quarterly, 2025-06-30) — Other Properties: 167491000.00
CNS balance_sheet (quarterly, 2025-06-30) — Other Receivables: 4163000.00
CNS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 134746000.00
CNS balance_sheet (quarterly, 2025-06-30) — Payables: 12625000.00
CNS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 12625000.00
CNS income_statement (quarterly, 2025-06-30) — Pretax Income: 53834000.00
CNS cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 250000.00
CNS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -85447000.00
CNS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2134000.00
CNS balance_sheet (quarterly, 2025-06-30) — Receivables: 77047000.00
CNS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 71893000.00
CNS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2828000.00
CNS cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -621000.00
CNS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -117510000.00
CNS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 90112000.00
CNS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 18078000.00
CNS balance_sheet (quarterly, 2025-06-30) — Share Issued: 58210217.00
CNS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 12161000.00
CNS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 528501000.00
CNS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 508467000.00
CNS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 1035424.00
CNS income_statement (quarterly, 2025-06-30) — Tax Provision: 12062000.00
CNS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
CNS balance_sheet (quarterly, 2025-06-30) — Total Assets: 751023000.00
CNS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 528501000.00
CNS balance_sheet (quarterly, 2025-06-30) — Total Debt: 141563000.00
CNS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 542321000.00
CNS income_statement (quarterly, 2025-06-30) — Total Expenses: 92799000.00
CNS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 208702000.00
CNS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 443858000.00
CNS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 196077000.00
CNS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 43327000.00
CNS balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 192000.00
CNS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 4192000.00
CNS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 4192000.00
CNS balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 7216560.00
CNS balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 319297000.00
CNS balance_sheet (quarterly, 2025-06-30) — Working Capital: 294540000.00
CNS income_statement (quarterly, 2025-09-30) — +Operating Expense: 19294000.00
CNS income_statement (quarterly, 2025-09-30) — +Total Revenue: 146826000.00
CNS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 8698000.00
CNS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 68326000.00
CNS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 982023000.00
CNS cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -354000.00
CNS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 218160000.00
CNS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 51205000.00
CNS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.81
CNS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 95730000.00
CNS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -2488000.00
CNS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 140279000.00
CNS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 582000.00
CNS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 98054000.00
CNS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 295678000.00
CNS cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -31747000.00
CNS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -17010000.00
CNS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -35256000.00
CNS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 55083000.00
CNS cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 20025000.00
CNS cash_flow (quarterly, 2025-09-30) — Change In Dividend Payable: 361000.00
CNS cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 4515000.00
CNS cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -21414000.00
CNS cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -5609000.00
CNS cash_flow (quarterly, 2025-09-30) — Change In Payable: 3240000.00
CNS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 23265000.00
CNS cash_flow (quarterly, 2025-09-30) — Change In Receivables: 4003000.00
CNS cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 4515000.00
CNS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 245000.00
CNS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 4444000.00
CNS cash_flow (quarterly, 2025-09-30) — Changes In Cash: 2817000.00
CNS balance_sheet (quarterly, 2025-09-30) — Common Stock: 582000.00
CNS cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -31747000.00
CNS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 550292000.00
CNS cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CNS cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -258000.00
CNS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 73525000.00
CNS balance_sheet (quarterly, 2025-09-30) — Current Assets: 366590000.00
CNS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 10139000.00
CNS cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -1488000.00
CNS cash_flow (quarterly, 2025-09-30) — Deferred Tax: -1488000.00
CNS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2997000.00
CNS income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 2519000.00
CNS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2997000.00
CNS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 2519000.00
CNS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 51572000.00
CNS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.81
CNS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 41711000.00
CNS income_statement (quarterly, 2025-09-30) — EBIT: 54007000.00
CNS income_statement (quarterly, 2025-09-30) — EBITDA: 57004000.00
CNS cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 80000.00
CNS balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 59972000.00
CNS cash_flow (quarterly, 2025-09-30) — End Cash Position: 98627000.00
CNS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -17010000.00
CNS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 52595000.00
CNS cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -692000.00
CNS income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 1551000.00
CNS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -4487000.00
CNS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 16775000.00
CNS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 20046000.00
CNS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 166188000.00
CNS income_statement (quarterly, 2025-09-30) — Gross Profit: 73301000.00
CNS balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 1318000.00
CNS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 550292000.00
CNS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -35256000.00
CNS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 218160000.00
CNS balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 218169000.00
CNS cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CNS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 140279000.00
CNS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 140279000.00
CNS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 9000.00
CNS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 28965000.00
CNS income_statement (quarterly, 2025-09-30) — Minority Interests: 77000.00
CNS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -258000.00
CNS cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -914000.00
CNS income_statement (quarterly, 2025-09-30) — Net Income: 41711000.00
CNS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 41711000.00
CNS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 41634000.00
CNS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 41711000.00
CNS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 41711000.00
CNS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 41634000.00
CNS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 41634000.00
CNS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -32768000.00
CNS cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 14795000.00
CNS balance_sheet (quarterly, 2025-09-30) — Net PPE: 166188000.00
CNS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -2488000.00
CNS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 530246000.00
CNS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 55453000.00
CNS income_statement (quarterly, 2025-09-30) — Normalized Income: 40547750.00
CNS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 55083000.00
CNS cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -1606000.00
CNS income_statement (quarterly, 2025-09-30) — Operating Income: 54007000.00
CNS income_statement (quarterly, 2025-09-30) — Operating Revenue: 146247000.00
CNS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 51004418.00
CNS balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -4487000.00
CNS income_statement (quarterly, 2025-09-30) — Other Gand A: 16775000.00
CNS income_statement (quarterly, 2025-09-30) — Other Income Expense: 1551000.00
CNS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1318000.00
CNS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 30619000.00
CNS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 11965000.00
CNS balance_sheet (quarterly, 2025-09-30) — Other Payable: 123000.00
CNS balance_sheet (quarterly, 2025-09-30) — Other Properties: 166188000.00
CNS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 2586000.00
CNS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 197624000.00
CNS balance_sheet (quarterly, 2025-09-30) — Payables: 10139000.00
CNS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 10139000.00
CNS income_statement (quarterly, 2025-09-30) — Pretax Income: 55558000.00
CNS cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 200000.00
CNS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -143822000.00
CNS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -2488000.00
CNS balance_sheet (quarterly, 2025-09-30) — Receivables: 70912000.00
CNS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 73047000.00
CNS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2997000.00
CNS cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -258000.00
CNS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -108271000.00
CNS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 111054000.00
CNS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 16775000.00
CNS balance_sheet (quarterly, 2025-09-30) — Share Issued: 58224453.00
CNS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 12337000.00
CNS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 550292000.00
CNS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 530246000.00
CNS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 387750.00
CNS income_statement (quarterly, 2025-09-30) — Tax Provision: 13924000.00
CNS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
CNS balance_sheet (quarterly, 2025-09-30) — Total Assets: 801612000.00
CNS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 550292000.00
CNS balance_sheet (quarterly, 2025-09-30) — Total Debt: 140279000.00
CNS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 579257000.00
CNS income_statement (quarterly, 2025-09-30) — Total Expenses: 92819000.00
CNS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 222355000.00
CNS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 435022000.00
CNS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 212216000.00
CNS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 48901000.00
CNS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1318000.00
CNS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 1551000.00
CNS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 1551000.00
CNS balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 7220035.00
CNS balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 319555000.00
CNS balance_sheet (quarterly, 2025-09-30) — Working Capital: 356451000.00
CNS income_statement (annual, 2025-12-31) — +Operating Expense: 81020000.00
CNS income_statement (quarterly, 2025-12-31) — +Operating Expense: 21747000.00
CNS income_statement (annual, 2025-12-31) — +Total Revenue: 578125000.00
CNS income_statement (quarterly, 2025-12-31) — +Total Revenue: 149020000.00
CNS balance_sheet (annual, 2025-12-31) — Accounts Payable: 8623000.00
CNS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 8623000.00
CNS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 79775000.00
CNS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 79775000.00
CNS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -34720000.00
CNS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -34720000.00
CNS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 992948000.00
CNS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 992948000.00
CNS cash_flow (annual, 2025-12-31) — Amortization Of Securities: 1080000.00
CNS cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: 59000.00
CNS balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 271034000.00
CNS balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 271034000.00
CNS income_statement (annual, 2025-12-31) — Basic Average Shares: 51168000.00
CNS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 51243000.00
CNS income_statement (annual, 2025-12-31) — Basic EPS: 2.99
CNS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.68
CNS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 183162000.00
CNS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 98627000.00
CNS cash_flow (annual, 2025-12-31) — Capital Expenditure: -5979000.00
CNS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -282000.00
CNS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 138326000.00
CNS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 138326000.00
CNS balance_sheet (annual, 2025-12-31) — Capital Stock: 583000.00
CNS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 583000.00
CNS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 145452000.00
CNS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 145452000.00
CNS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 310895000.00
CNS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 310895000.00
CNS cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -126924000.00
CNS cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -31754000.00
CNS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 73837000.00
CNS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 7583000.00
CNS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 8356000.00
CNS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 39080000.00
CNS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -120444000.00
CNS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1058000.00
CNS cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 9565000.00
CNS cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 20642000.00
CNS cash_flow (annual, 2025-12-31) — Change In Dividend Payable: 138000.00
CNS cash_flow (quarterly, 2025-12-31) — Change In Dividend Payable: -75000.00
CNS cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -5064000.00
CNS cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: 232000.00
CNS cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -319528000.00
CNS cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -53649000.00
CNS cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -6900000.00
CNS cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -1424000.00
CNS cash_flow (annual, 2025-12-31) — Change In Payable: 65000.00
CNS cash_flow (quarterly, 2025-12-31) — Change In Payable: 382000.00
CNS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 9630000.00
CNS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 21024000.00
CNS cash_flow (annual, 2025-12-31) — Change In Receivables: -18022000.00
CNS cash_flow (quarterly, 2025-12-31) — Change In Receivables: -11005000.00
CNS cash_flow (annual, 2025-12-31) — Change In Tax Payable: -5064000.00
CNS cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: 232000.00
CNS cash_flow (annual, 2025-12-31) — Change In Working Capital: -334820000.00
CNS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -45054000.00
CNS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -5300000.00
CNS cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -11729000.00
CNS cash_flow (annual, 2025-12-31) — Changes In Cash: -38251000.00
CNS cash_flow (quarterly, 2025-12-31) — Changes In Cash: 47721000.00
CNS balance_sheet (annual, 2025-12-31) — Common Stock: 583000.00
CNS balance_sheet (quarterly, 2025-12-31) — Common Stock: 583000.00
CNS cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -126924000.00
CNS cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -31754000.00
CNS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 561953000.00
CNS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 561953000.00
CNS cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
CNS cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CNS cash_flow (annual, 2025-12-31) — Common Stock Payments: -28416000.00
CNS cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -1560000.00
CNS income_statement (annual, 2025-12-31) — Cost Of Revenue: 297360000.00
CNS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 81746000.00
CNS balance_sheet (annual, 2025-12-31) — Current Assets: 392535000.00
CNS balance_sheet (quarterly, 2025-12-31) — Current Assets: 392535000.00
CNS balance_sheet (annual, 2025-12-31) — Current Liabilities: 10592000.00
CNS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 10592000.00
CNS cash_flow (annual, 2025-12-31) — Deferred Income Tax: 561000.00
CNS cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -1429000.00
CNS cash_flow (annual, 2025-12-31) — Deferred Tax: 561000.00
CNS cash_flow (quarterly, 2025-12-31) — Deferred Tax: -1429000.00
CNS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 11714000.00
CNS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 3058000.00
CNS income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 9786000.00
CNS income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 2535000.00
CNS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 11714000.00
CNS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 3058000.00
CNS income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 9786000.00
CNS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 2535000.00
CNS income_statement (annual, 2025-12-31) — Diluted Average Shares: 51526000.00
CNS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 51639000.00
CNS income_statement (annual, 2025-12-31) — Diluted EPS: 2.97
CNS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.68
CNS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 153217000.00
CNS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 34879000.00
CNS income_statement (annual, 2025-12-31) — EBIT: 199745000.00
CNS income_statement (quarterly, 2025-12-31) — EBIT: 45527000.00
CNS income_statement (annual, 2025-12-31) — EBITDA: 211459000.00
CNS income_statement (quarterly, 2025-12-31) — EBITDA: 48585000.00
CNS cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 1693000.00
CNS cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 256000.00
CNS balance_sheet (annual, 2025-12-31) — Employee Benefits: 80614000.00
CNS balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 80614000.00
CNS cash_flow (annual, 2025-12-31) — End Cash Position: 146604000.00
CNS cash_flow (quarterly, 2025-12-31) — End Cash Position: 146604000.00
CNS cash_flow (annual, 2025-12-31) — Financing Cash Flow: 73837000.00
CNS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 7583000.00
CNS cash_flow (annual, 2025-12-31) — Free Cash Flow: -126423000.00
CNS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 776000.00
CNS cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -8712000.00
CNS cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 2248000.00
CNS income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 4885000.00
CNS income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -3239000.00
CNS balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -4657000.00
CNS balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -4657000.00
CNS income_statement (annual, 2025-12-31) — General And Administrative Expense: 71234000.00
CNS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 19212000.00
CNS balance_sheet (annual, 2025-12-31) — Goodwill: 18790000.00
CNS balance_sheet (quarterly, 2025-12-31) — Goodwill: 18790000.00
CNS balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 20040000.00
CNS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 20040000.00
CNS balance_sheet (annual, 2025-12-31) — Gross PPE: 197130000.00
CNS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 197130000.00
CNS income_statement (annual, 2025-12-31) — Gross Profit: 280765000.00
CNS income_statement (quarterly, 2025-12-31) — Gross Profit: 67274000.00
CNS balance_sheet (annual, 2025-12-31) — Income Tax Payable: 1650000.00
CNS balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 1650000.00
CNS balance_sheet (annual, 2025-12-31) — Invested Capital: 561953000.00
CNS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 561953000.00
CNS cash_flow (annual, 2025-12-31) — Investing Cash Flow: 8356000.00
CNS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 39080000.00
CNS balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 271034000.00
CNS balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 271034000.00
CNS balance_sheet (annual, 2025-12-31) — Investments And Advances: 271042000.00
CNS balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 271042000.00
CNS cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
CNS cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CNS balance_sheet (annual, 2025-12-31) — Leases: 52864000.00
CNS balance_sheet (quarterly, 2025-12-31) — Leases: 52864000.00
CNS balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 138326000.00
CNS balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 138326000.00
CNS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 138326000.00
CNS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 138326000.00
CNS balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 8000.00
CNS balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 8000.00
CNS balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 34180000.00
CNS balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 34180000.00
CNS balance_sheet (annual, 2025-12-31) — Minority Interest: 71895000.00
CNS balance_sheet (quarterly, 2025-12-31) — Minority Interest: 71895000.00
CNS income_statement (annual, 2025-12-31) — Minority Interests: -4181000.00
CNS income_statement (quarterly, 2025-12-31) — Minority Interests: 4176000.00
CNS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -28416000.00
CNS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -1560000.00
CNS cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 1119000.00
CNS cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 81000.00
CNS income_statement (annual, 2025-12-31) — Net Income: 153217000.00
CNS income_statement (quarterly, 2025-12-31) — Net Income: 34879000.00
CNS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 153217000.00
CNS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 34879000.00
CNS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 157398000.00
CNS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 30703000.00
CNS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 153217000.00
CNS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 34879000.00
CNS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 153217000.00
CNS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 34879000.00
CNS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 157398000.00
CNS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 30703000.00
CNS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 157398000.00
CNS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 30703000.00